These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15042672)

  • 1. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.
    Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M
    Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
    Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
    J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p38 transduction pathway in prostatic neoplasia.
    Ricote M; García-Tuñón I; Bethencourt F; Fraile B; Onsurbe P; Paniagua R; Royuela M
    J Pathol; 2006 Feb; 208(3):401-7. PubMed ID: 16369914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
    Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
    Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
    Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
    Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over expression of interleukin-1alpha, interleukin-1beta and interleukin-1 receptor antagonist in testicular tissues from sexually immature mice as compared to adult mice.
    Huleihel M; Lunenfeld E; Blindman A; Prinsloo I; Potashnik G
    Eur Cytokine Netw; 2003; 14(1):27-33. PubMed ID: 12799211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation.
    Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC
    Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of receptor binding sites on IL-1 beta by reconstruction of IL-1ra-like domains.
    Boraschi D; Bossù P; Ruggiero P; Tagliabue A; Bertini R; Macchia G; Gasbarro C; Pellegrini L; Melillo G; Ulisse E; Visconti U; Bizzarri C; Del Grosso E; Mackay AR; Frascotti G; Frigerio F; Grifantini R; Grandi G
    J Immunol; 1995 Nov; 155(10):4719-25. PubMed ID: 7594472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
    Jouvenne P; Vannier E; Dinarello CA; Miossec P
    Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential binding of human interleukin-1 (IL-1) receptor antagonist to natural and recombinant soluble and cellular IL-1 type I receptors.
    Svenson M; Nedergaard S; Heegaard PM; Whisenand TD; Arend WP; Bendtzen K
    Eur J Immunol; 1995 Oct; 25(10):2842-50. PubMed ID: 7589081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty.
    Wang X; Romanic AM; Yue TL; Feuerstein GZ; Ohlstein EH
    Biochem Biophys Res Commun; 2000 Apr; 271(1):138-43. PubMed ID: 10777693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of interleukin-1 alpha, its type I receptor and antagonist in keratocystic odontogenic tumors.
    Suyama Y; Kubota Y; Ninomiya T; Shirasuna K
    J Oral Pathol Med; 2008 Oct; 37(9):560-4. PubMed ID: 18624935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders.
    Tominaga K; Habu M; Sukedai M; Hirota Y; Takahashi T; Fukuda J
    Arch Oral Biol; 2004 Jun; 49(6):493-9. PubMed ID: 15099807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy.
    Vannier E; Kaser A; Atkins MB; Fantuzzi G; Dinarello CA; Mier JW; Tilg H
    Eur Cytokine Netw; 1999 Mar; 10(1):37-42. PubMed ID: 10210771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma).
    Nuñez C; Cansino JR; Bethencourt F; Pérez-Utrilla M; Fraile B; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
    Histopathology; 2008 Aug; 53(2):166-76. PubMed ID: 18752500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity.
    McNamee EN; Ryan KM; Kilroy D; Connor TJ
    Eur J Pharmacol; 2010 Jan; 626(2-3):219-28. PubMed ID: 19818755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.